Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy

Liver International

Volumn 33, Issue 2, 2013, Pages 180-189

  Kim, Beom K ^a,b   Oh, Hyun J ^a   Park, Jun Y ^a,b   Kim, Do Y ^a,b   Ahn, Sang H ^a,b,c   Han, Kwang H ^a,b,c   Park, Yehyun ^a   J Yoo, Eun ^a   Park, Young N ^a,b,c   Kim, Seung U ^a,b  

^a Yonsei University   (South Korea)

^b Liver Cirrhosis Clinical Research Centre   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Change; Cirrhosis; Laennec staging system; Liver stiffness; Liver related event

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; ELASTICITY IMAGING TECHNIQUES; ENDPOINT DETERMINATION; FEMALE; HEPATITIS B; HISTOLOGICAL TECHNIQUES; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; REPUBLIC OF KOREA; STATISTICS, NONPARAMETRIC;

EID: 84872139145     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12020     Document Type: Article

References (41)

1. Anthony PP, Ishak KG, Nayak NC, et al. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978; 31: 395-414.
2. D'amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-31.
3. Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G. Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol 2006; 44: 111-7.
4. Germani G, Dhillon A, Andreana L, et al. Histological subclassification of cirrhosis. Hepatology 2010; 52: 804-5.
5. Kumar M, Sakhuja P, Kumar A, et al. Histological subclassification of cirrhosis based on histological-haemodynamic correlation. Aliment Pharmacol Ther 2008; 27: 771-9.
6. Wanless IR, Sweeney G, Dhillon AP, et al. Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia. Blood 2002; 100: 1566-9.
7. Kim MY, Cho MY, Baik SK, et al. Journal of hepatology: Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension, 2011.
8. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
9. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15-20.
10. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. The American journal of surgical pathology 1995; 19: 1409-17.
11. Oh H, Kim S, Park J, et al. Histological sub-classification of cirrhosis using Laennec staging system is useful for the stratification of prognosis in patients with liver cirrhosis. Hepatology 2011; 54Suppl: 1264A.
12. Dienstag JL, Goldin RD, Heathcote EJ, et al. Histological outcome during long-term lamivudine therapy. Gastroenterology 2003; 124: 105-17.
13. Poynard T, Mchutchison J, Manns M, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122: 1303-13.
14. Shiratori Y, Imazeki F, Moriyama M, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 2000; 132: 517-24.
15. Spinzi G, Terruzzi V, Minoli G. Liver biopsy. N Engl J Med 2001; 344: 2030.
16. Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology 2011; 53: 325-35.
17. Bae RC, Cho HJ, Oh JT, et al. Clinical factors influencing liver stiffness as measured by transient elastography (Fibroscan) in patients with chronic liver disease. Korean J Hepatol 2010; 16: 123-30.
18. Jung KS, Kim SU, Ahn SH, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011; 53: 885-94.
19. Kim SU, Han KH, Ahn SH. Transient elastography in chronic hepatitis B: an Asian perspective. World J Gastroenterol 2010; 16: 5173-80.
20. Kim BK, Kim Do Y, Han KH, et al. Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. Am J Gastroenterol 2011; 106: 1654-62, 730.
21. Foucher J, Chanteloup E, Vergniol J, et al., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-8.
22. Lee KS, Kim DJ. Management of Chronic Hepatitis B. Korean J Hepatol 2007; 13: 447-88.
23. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-42.
24. Lok AS, Mcmahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-2.
25. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
26. Ripoll C, Groszmann R, Garcia Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133: 481-8.
27. Patch D, Dagher L. Acute variceal bleeding: general management. World J Gastroenterol 2001; 7: 466-75.
28. Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nature reviews Gastroenterology & hepatology 2010; 7: 515-25.
29. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841-56.
30. Gins P, Arroyo V. Hepatorenal syndrome. J Am Soc Nephrol 1999; 10: 1833-9.
31. Korean liver cancer study group and national cancer center. Practice guidelines for management of hepatocellular carcinoma 2009. The Korean journal of hepatology 2009; 15: 391-423.
32. Weber R, Sabin CA, Friis-Mller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166: 1632-41.
33. Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J 2005; 47: 458-72.
34. Garcia Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology 2010; 51: 1445-9.
35. Cardenas A, Gins P. Management of complications of cirrhosis in patients awaiting liver transplantation. J Hepatol 2005; 42 (Suppl 1): S124-33.
36. Kim BK, Park YN, Kim Do Y, et al. Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement. Digestion 2012; 85: 219-27.
37. Kazemi F, Kettaneh A, N'Kontchou G, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45: 230-5.
38. Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-7.
39. Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008; 134: 8-14.
40. Da Lee M, Moon EJ, Hwang JA, et al. Factors associated with liver stiffness in chronic liver disease. Korean J Hepatol 2009; 15: 464-73.
41. Kim BK, Han KH, Park JY, et al. A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients. Liver international : official journal of the International Association for the Study of the Liver 2010; 30: 1073-81.